ARIELLE LANDRY: Open Payments
NPI 1609572049 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,554 in 56 payments from 20 companies in 2025. Trend: 2023 $347 · 2024 $1,123 · 2025 $1,554
Food & beverage: $1,455Education: $99
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $307 |
| Novartis Pharmaceuticals Corporation | 9 | $252 |
| Janssen Biotech, Inc. | 2 | $144 |
| AstraZeneca Pharmaceuticals LP | 7 | $126 |
| Merck Sharp & Dohme LLC | 5 | $105 |
| Geron Corporation | 1 | $104 |
| ABBVIE INC. | 5 | $99 |
| GENZYME CORPORATION | 3 | $85 |
| Incyte Corporation | 3 | $70 |
| Eisai Inc. | 2 | $39 |
Products named: Enhertu, KISQALI, RYBREVANT, KEYTRUDA, RYTELO, DATROWAY, INJECTAFER, LYNPARZA.
Industry payments across LA — which companies pay providers there.
